Sabina Berezowska

6.3k total citations · 1 hit paper
114 papers, 2.4k citations indexed

About

Sabina Berezowska is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Sabina Berezowska has authored 114 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pulmonary and Respiratory Medicine, 37 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Sabina Berezowska's work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Autophagy in Disease and Therapy (16 papers). Sabina Berezowska is often cited by papers focused on Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Autophagy in Disease and Therapy (16 papers). Sabina Berezowska collaborates with scholars based in Switzerland, Germany and United States. Sabina Berezowska's co-authors include Rupert Langer, Ralph A. Schmid, Mario P. Tschan, Olivia Adams, Anna M. Schläfli, Thomas M. Marti, Karl Sotlar, Hans‐Peter Horny, Ren‐Wang Peng and Patrick Dorn and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sabina Berezowska

106 papers receiving 2.4k citations

Hit Papers

The cGAS–STING pathway drives type I IFN immunopathology ... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabina Berezowska Switzerland 27 926 622 590 538 427 114 2.4k
Carolin Mogler Germany 29 1.1k 1.2× 397 0.6× 309 0.5× 656 1.2× 419 1.0× 126 2.7k
Kwok‐Wah Chan Hong Kong 26 1.1k 1.2× 464 0.7× 288 0.5× 1.1k 2.0× 417 1.0× 53 2.6k
Walter E. Aulitzky Germany 34 1.4k 1.5× 502 0.8× 372 0.6× 1.1k 2.0× 225 0.5× 121 3.6k
Alexander C. Mackinnon United States 29 1.1k 1.2× 453 0.7× 839 1.4× 638 1.2× 258 0.6× 93 2.7k
Marco Novelli United Kingdom 30 739 0.8× 501 0.8× 907 1.5× 799 1.5× 424 1.0× 84 3.4k
Samia Mourah France 33 1.5k 1.6× 582 0.9× 280 0.5× 1.3k 2.3× 200 0.5× 162 3.1k
Mark N. Kirstein United States 21 1.4k 1.6× 362 0.6× 1.0k 1.8× 1.4k 2.6× 251 0.6× 56 3.4k
Patricia Fetsch United States 35 1.3k 1.5× 967 1.6× 752 1.3× 2.1k 3.9× 318 0.7× 73 3.9k
Rossitza Lazova United States 28 886 1.0× 393 0.6× 193 0.3× 760 1.4× 523 1.2× 91 2.3k
Štefan Porubský Germany 30 722 0.8× 768 1.2× 342 0.6× 312 0.6× 170 0.4× 92 2.3k

Countries citing papers authored by Sabina Berezowska

Since Specialization
Citations

This map shows the geographic impact of Sabina Berezowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabina Berezowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabina Berezowska more than expected).

Fields of papers citing papers by Sabina Berezowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabina Berezowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabina Berezowska. The network helps show where Sabina Berezowska may publish in the future.

Co-authorship network of co-authors of Sabina Berezowska

This figure shows the co-authorship network connecting the top 25 collaborators of Sabina Berezowska. A scholar is included among the top collaborators of Sabina Berezowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabina Berezowska. Sabina Berezowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qian, Chaoyang Zhang, Thomas Kunzke, et al.. (2025). Metabolic heterogeneity in tumor cells impacts immunology in lung squamous cell carcinoma. OncoImmunology. 14(1). 2457797–2457797. 5 indexed citations
2.
3.
Berezowska, Sabina, et al.. (2023). Impact of template-based synoptic reporting on completeness of surgical pathology reports. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 484(1). 31–36. 7 indexed citations
4.
Shen, Jian, Na Sun, Jun Wang, et al.. (2023). Patterns of Carbon-Bound Exogenous Compounds Impact Disease Pathophysiology in Lung Cancer Subtypes in Different Ways. ACS Nano. 17(17). 16396–16411. 3 indexed citations
5.
Leichtle, Alexander, Sabina Berezowska, Sabina A. Guler, et al.. (2023). Signs of Alveolar Collapse in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis and Systemic Sclerosis Revealed by Inspiration and Expiration Computed Tomography. SHILAP Revista de lepidopterología. 3(4). 471–483. 2 indexed citations
6.
Domizio, Jérémy Di, Muhammet F. Gülen, Fanny Saidoune, et al.. (2022). The cGAS–STING pathway drives type I IFN immunopathology in COVID-19. Nature. 603(7899). 145–151. 371 indexed citations breakdown →
7.
Fung, Christian, Ferdinando Cerciello, Evelyn Herrmann, et al.. (2022). Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases—a Single-Center Study in 190 Patients. JTO Clinical and Research Reports. 3(11). 100413–100413. 1 indexed citations
8.
Shen, Jian, Na Sun, Thomas Kunzke, et al.. (2022). Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients. Cancer Communications. 42(6). 517–535. 30 indexed citations
9.
Schmid, Ralph A., et al.. (2021). Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Advanced Non-Small Cell Lung Cancer after Neoadjuvant Therapy. Cells. 10(10). 2731–2731. 6 indexed citations
10.
Berezowska, Sabina, Karine Lefort, Kalliopi Ioannidou, et al.. (2021). Postmortem Cardiopulmonary Pathology in Patients with COVID-19 Infection: Single-Center Report of 12 Autopsies from Lausanne, Switzerland. Diagnostics. 11(8). 1357–1357. 9 indexed citations
11.
Schläfli, Anna M., Marta Pinto, Magali Humbert, et al.. (2021). Increased LAMP2A levels correlate with a shorter disease-free survival of HER2 negative breast cancer patients and increased breast cancer cell viability. Biochemical and Biophysical Research Communications. 569. 47–53. 7 indexed citations
13.
Neppl, Christina, Inti Zlobec, Ralph A. Schmid, & Sabina Berezowska. (2019). Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung—a single-center analysis of 354 cases. Modern Pathology. 33(5). 802–811. 33 indexed citations
14.
Berezowska, Sabina, Manuela Funke-Chambour, Alexander Pöllinger, & Stephan Schäfer. (2019). Multidisziplinäre Diskussion – der Goldstandard der Diagnostik interstitieller Lungenerkrankungen. Der Pathologe. 41(1). 14–20. 1 indexed citations
15.
Xu, Duo, Haitang Yang, Yang Zhang, et al.. (2019). Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma. Cancers. 11(10). 1502–1502. 29 indexed citations
16.
Gao, Yanyun, Nina Hobi, Sabina Berezowska, et al.. (2018). Tumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549. Neoplasia. 21(2). 185–196. 46 indexed citations
17.
Baumgartner, Ulrich, Stefan Haemmig, Stephan Schäfer, et al.. (2016). miR-29b Mediates NF-κB Signaling in KRAS-Induced Non–Small Cell Lung Cancers. Cancer Research. 76(14). 4160–4169. 48 indexed citations
18.
Drecoll, Enken, Ulrich Nitsche, Sabina Berezowska, et al.. (2014). Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma. International Journal of Colorectal Disease. 29(6). 663–671. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026